Clinical Trial Update: Pazopanib in Treating Patients With Recurrent or Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating pazopanib for recurrent or metastatic breast cancer has completed with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Pazopanib (Pazopanib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Breast Cancer, Recurrent Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-12-14